thalidomide has been researched along with Angiitis in 9 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thalidomide is used for the acute treatment and suppression of the cutaneous manifestations of erythema nodosum leprosum (ENL)." | 7.75 | Thalidomide levels in patients with erythema nodosum leprosum. ( Valente, Mdo S; Vieira, JL, 2009) |
| "We found that thalidomide, through its antiinflammatory and antiproliferative effects, significantly inhibits neointimal hyperplasia in balloon-injured rat carotid arteries." | 7.72 | Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery. ( Chae, IH; Choi, DJ; Jeon, SI; Kim, DH; Kim, HS; Koo, BK; Lee, MM; Oh, BH; Park, KW; Park, SJ; Park, YB; Yang, HM; Youn, SW, 2004) |
| "Thalidomide therapy was started for four patients with significant morbidity from Behçet's syndrome and for one patient with bowel-associated dermatosis-arthritis syndrome." | 5.27 | Thalidomide effects in Behçet's syndrome and pustular vasculitis. ( Cavallo, T; Daniels, JC; Jorizzo, JL; Rudloff, HB; Schmalstieg, EJ; Schmalstieg, FC; Solomon, AR; Taylor, RS, 1986) |
| "Thalidomide is used for the acute treatment and suppression of the cutaneous manifestations of erythema nodosum leprosum (ENL)." | 3.75 | Thalidomide levels in patients with erythema nodosum leprosum. ( Valente, Mdo S; Vieira, JL, 2009) |
| "We found that thalidomide, through its antiinflammatory and antiproliferative effects, significantly inhibits neointimal hyperplasia in balloon-injured rat carotid arteries." | 3.72 | Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery. ( Chae, IH; Choi, DJ; Jeon, SI; Kim, DH; Kim, HS; Koo, BK; Lee, MM; Oh, BH; Park, KW; Park, SJ; Park, YB; Yang, HM; Youn, SW, 2004) |
| "Thalidomide is a synthetic glutamic acid derivative first introduced in 1956 in Germany as an over the counter medications." | 2.50 | [Current therapeutic indications of thalidomide and lenalidomide]. ( Cosiglio, FJ; Ordi-Ros, J, 2014) |
| "Thalidomide therapy was started for four patients with significant morbidity from Behçet's syndrome and for one patient with bowel-associated dermatosis-arthritis syndrome." | 1.27 | Thalidomide effects in Behçet's syndrome and pustular vasculitis. ( Cavallo, T; Daniels, JC; Jorizzo, JL; Rudloff, HB; Schmalstieg, EJ; Schmalstieg, FC; Solomon, AR; Taylor, RS, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ordi-Ros, J | 1 |
| Cosiglio, FJ | 1 |
| Baek, MC | 1 |
| Jung, B | 1 |
| Kang, H | 1 |
| Lee, HS | 1 |
| Bae, JS | 1 |
| Hatemi, I | 1 |
| Hatemi, G | 1 |
| Çelik, AF | 1 |
| Vieira, JL | 1 |
| Valente, Mdo S | 1 |
| Francès, C | 1 |
| Barete, S | 1 |
| Ayoub, N | 1 |
| Piette, JC | 1 |
| SCHULZ, KH | 1 |
| JAENNER, M | 1 |
| Park, SJ | 1 |
| Kim, HS | 1 |
| Yang, HM | 1 |
| Park, KW | 1 |
| Youn, SW | 1 |
| Jeon, SI | 1 |
| Kim, DH | 1 |
| Koo, BK | 1 |
| Chae, IH | 1 |
| Choi, DJ | 1 |
| Oh, BH | 1 |
| Lee, MM | 1 |
| Park, YB | 1 |
| Silingardi, M | 1 |
| Iotti, M | 1 |
| Trenti, C | 1 |
| Salvarani, C | 1 |
| Iori, I | 1 |
| Jorizzo, JL | 1 |
| Schmalstieg, FC | 1 |
| Solomon, AR | 1 |
| Cavallo, T | 1 |
| Taylor, RS | 1 |
| Rudloff, HB | 1 |
| Schmalstieg, EJ | 1 |
| Daniels, JC | 1 |
3 reviews available for thalidomide and Angiitis
| Article | Year |
|---|---|
[Current therapeutic indications of thalidomide and lenalidomide].
Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents; Antineoplastic Agents; Collagen Diseases; End | 2014 |
Novel insight into drug repositioning: Methylthiouracil as a case in point.
Topics: Animals; Anti-Inflammatory Agents; Antithyroid Agents; Arthritis, Rheumatoid; Biomarkers; Doxycyclin | 2015 |
Systemic vasculitis and the gut.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Behcet Syndrome; Cyclophosphamide; Gastr | 2017 |
6 other studies available for thalidomide and Angiitis
| Article | Year |
|---|---|
Thalidomide levels in patients with erythema nodosum leprosum.
Topics: Adult; Chromatography, Liquid; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; M | 2009 |
[Classification of dermatologic manifestations in lupus erythematosus].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Antimalarials; Clinical Trials as Topic; Dapsone; Dermato | 2003 |
[ALLERGIC VASCULITIS WITH THROMBOCYTOPENIA CAUSED BY THALIDOMIDE].
Topics: Arteritis; Drug Hypersensitivity; Exanthema; Leg; Phlebitis; Purpura; Purpura, Thrombocytopenic; Tha | 1963 |
Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carotid Arteries; Carotid Stenosis; Catheterizatio | 2004 |
Thalidomide, deep venous thrombosis and vasculitis.
Topics: Aged; Female; Humans; Lupus Erythematosus, Systemic; Thalidomide; Vasculitis; Venous Thrombosis | 2004 |
Thalidomide effects in Behçet's syndrome and pustular vasculitis.
Topics: Antigen-Antibody Complex; Behcet Syndrome; Cell Line; Cell Migration Inhibition; Glycoproteins; Memb | 1986 |